Investor Relations

Investor Relations

Feb 4 8:30 AM EST Feb 4, 2022 | 8:30 AM EST
Regeneron Pharmaceuticals Q4 2021 Earnings Conference Call

Jan 10 10:30 AM EST Jan 10, 2022 | 10:30 AM EST
40th Annual J.P. Morgan Healthcare Conference

Dec 13 4:30 PM EST Dec 13, 2021 | 4:30 PM EST
Regeneron Investor Event, ASH 2021

btn Events

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.

Analyst Center


Analyst Center

Interactive and downloadable financial data for investors and analysts

btn Analyst Center

Contact us

Investor Relations


Media Relations

Email Alerts

IR Tools